US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Yesterday's Top Gainers

715.26

+1.800.25%

Number of Gainers:22

Number of Losers:31

Number of Flat:4

PE:- -

High:717.32

Open:713.46

Low:707.96

Close:713.46

Loading ...

TRONOX (TROX) Receives a Buy from Alembic Global

Celanese, Li Auto announce joint initiative over ultra-low emission innovation

NCS Multistage Holdings: Have Not Experienced Significant Impact on Business From Escalating Global Trade Tensions

THOMSON REUTERS

NCS Multistage Holdings, Inc. Q1 Revenue USD 50 Million

THOMSON REUTERS

Tronox Q1 Adjusted Ebitda Margin 15.2%

THOMSON REUTERS

Tronox Holdings Plc: Maintaining Previous Guidance for 2025 Revenue

THOMSON REUTERS

NCS Multistage Holdings, Inc. Announces First Quarter 2025 Results

Central Puerto Announces Reporting Date for the First Quarter 2025 Financial Results Conference Call and Webcast

REGENXBIO to Host Conference Call on May 12 to Discuss First Quarter 2025 Financial Results and Recent Operational Highlights

Why are Bitcoin and altcoins like XRP, Pepe, VeChain going down? 7 seconds ago

CyberArk Software Ltd. (CYBR): Among Billionaire George Soros’ Mid-Cap Stocks With Huge Upside Potential

Humacyte Insiders Placed Bullish Bets Worth US$949.4k

Simply Wall St.

Are Investors Undervaluing Napco Security Technologies, Inc. (NASDAQ:NSSC) By 30%?

Simply Wall St.

BRIEF-Acurx Pharmaceuticals To Discuss First Quarter 2025 Financial Results

3 Promising Penny Stocks With Market Caps Up To $400M

Simply Wall St.

Acurx Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 13, 2025 Conference Call and Provide Business Update

THOMSON REUTERS

Acurx Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 13, 2025 Conference Call and Provide Business Update

NAPCO Security Technologies to Announce Fiscal Third Quarter 2025 Results Monday, May 5, 2025

Purple Biotech Reports Final Data from Phase 2 Study of CM24 in Pancreatic Cancer Patients at AACR 2025 Annual Meeting: Improved Outcomes and Significant Efficacy in Biomarker-Enriched Subgroups

Uxin Ltd. Reports 116.8% Surge in Transaction Volume for Q4 2024; Achieves Positive Adjusted EBITDA for First Time

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4563/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4563","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4563\",,,,,undefined,":{"symbol":"BK4563","market":"US","secType":"PLATE","nameCN":"Yesterday's Top Gainers","latestPrice":715.26337,"timestamp":1746043199999,"preClose":713.4594,"halted":0,"volume":68577768,"delay":0,"changeRate":0.002528,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":1.803955,"latestTime":"04-30 16:00:00 EDT","open":713.4603,"high":717.318,"low":707.95917,"amount":770603481.372595,"amplitude":0.013118,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1746057600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":2.067468,"peRate":32.979768,"turnoverRate":0.012371,"increases":22,"decrements":31,"flats":2,"marketCap":128036367931,"floatMarketCap":73188022255},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4563\",,,,,undefined,":{"symbol":"BK4563","high":717.318,"amplitude":0.013118,"preClose":713.4594,"low":707.95917,"pbRate":"2.067468","latestPrice":715.26337,"volume":68577768,"delay":0,"open":713.4603,"prevYearClose":733.5465,"prevWeekClose":702.7086,"prevMonthClose":750.7285,"prevQuarterClose":750.7285,"fiveDayClose":702.7436,"twentyDayClose":754.866,"sixtyDayClose":719.6281,"secType":"PLATE","market":"US","turnoverRate":0.012371,"peRate":32.979768,"marketCap":128036367931,"floatMarketCap":73188022255,"timestamp":1746043199999,"nameCN":"Yesterday's Top Gainers"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4563\",,,,undefined,":{"bkCode":"BK4563","up":22,"down":31,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4563\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532926310","title":"TRONOX (TROX) Receives a Buy from Alembic Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2532926310","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532926310?lang=en_us&edition=fundamental","pubTime":"2025-05-01 05:36","pubTimestamp":1746049013,"startTime":"0","endTime":"0","summary":"Alembic Global analyst Hassan Ahmed maintained a Buy rating on TRONOX (TROX – Research Report) today and set a price target of $17.00. According to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/tronox-trox-receives-a-buy-from-alembic-global?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/tronox-trox-receives-a-buy-from-alembic-global?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4090","BK4563","TROX"],"gpt_icon":0},{"id":"2532099733","title":"Celanese, Li Auto announce joint initiative over ultra-low emission innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2532099733","media":"TipRanks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532099733?lang=en_us&edition=fundamental","pubTime":"2025-05-01 04:50","pubTimestamp":1746046244,"startTime":"0","endTime":"0","summary":"Discover companies with rock-solid fundamentals in  TipRanks' Smart Value Newsletter.Receive undervalued stocks, resilient to market uncertainty,  delivered straight to your inbox.Celanese enters cooperation with Dunn-Edwards for Carbon Capture, Utlization. Celanese price target lowered to $45 from $65 at Mizuho. Celanese price target lowered to $71 from $76 at KeyBanc. Celanese price target lowered to $52 from $56 at RBC Capital. Celanese price target lowered to $40 from $55 at Wells Fargo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/celanese-li-auto-announce-joint-205044927.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/celanese-li-auto-announce-joint-205044927.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4503","CE","BK4588","BK4099","BK4526","BK4551","LI","BK4109","BK4555","BK4563","BK4548","BK4585","EVS.SI"],"gpt_icon":1},{"id":"2532907096","title":"NCS Multistage Holdings: Have Not Experienced Significant Impact on Business From Escalating Global Trade Tensions","url":"https://stock-news.laohu8.com/highlight/detail?id=2532907096","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532907096?lang=en_us&edition=fundamental","pubTime":"2025-05-01 04:15","pubTimestamp":1746044126,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUA8F0HTL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","NCSM","BK4179"],"gpt_icon":0},{"id":"2532932100","title":"NCS Multistage Holdings, Inc. Q1 Revenue USD 50 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2532932100","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532932100?lang=en_us&edition=fundamental","pubTime":"2025-05-01 04:15","pubTimestamp":1746044126,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nPLXF79A5A:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","NCSM","BK4179"],"gpt_icon":0},{"id":"2532226093","title":"Tronox Q1 Adjusted Ebitda Margin 15.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532226093","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532226093?lang=en_us&edition=fundamental","pubTime":"2025-05-01 04:15","pubTimestamp":1746044110,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nPLX92BF3C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TROX","BK4090","BK4563"],"gpt_icon":0},{"id":"2532099669","title":"Tronox Holdings Plc: Maintaining Previous Guidance for 2025 Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2532099669","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532099669?lang=en_us&edition=fundamental","pubTime":"2025-05-01 04:15","pubTimestamp":1746044110,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nPLX92BF3C:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","BK4090","TROX"],"gpt_icon":0},{"id":"2532501095","title":"NCS Multistage Holdings, Inc. Announces First Quarter 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2532501095","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532501095?lang=en_us&edition=fundamental","pubTime":"2025-05-01 04:15","pubTimestamp":1746044100,"startTime":"0","endTime":"0","summary":"Total revenues of $50.0 million, a 14% year-over-year improvement. Gross margin improved to 42% from 39%; adjusted gross margin improved to 44% from 40% in the first quarter of 2024. Net income of $4.1 million and diluted earnings per share of $1.51, an improvement compared to $2.1 million and diluted earnings per share of $0.82 one year ago. Adjusted EBITDA of $8.2 million, a $2.1 million year-over-year improvement. $23.0 million in cash and $7.6 million of total debt as of March 31, 2025. NCS’s Chief Executive Officer, Ryan Hummer commented,“NCS had a strong start to 2025, with total revenues and Adjusted EBITDA for the first quarter exceeding our expectations as provided in the last earnings call, led by our performance in Canada.We have not experienced a significant impact on our business from escalating global trade tensions, and we expect that to continue to be the case in the second quarter of 2025. However, suchglobal trade tensions and potential additional U.S. tariffs—along w","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ncs-multistage-holdings-inc-announces-201500364.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4563","NCSM","BK4179"],"gpt_icon":0},{"id":"2532997300","title":"Central Puerto Announces Reporting Date for the First Quarter 2025 Financial Results Conference Call and Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2532997300","media":"Newsfile","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532997300?lang=en_us&edition=fundamental","pubTime":"2025-05-01 04:08","pubTimestamp":1746043680,"startTime":"0","endTime":"0","summary":"Buenos Aires, Argentina-- - Central Puerto S.A   one of the largest private sector power generation companies in Argentina, will issue a press release announcing its First Quarter results on May 12, 2025. Mr. Fernando Bonnet, Chief Executive Officer, Mr. Enrique Terraneo, Chief Financial Officer and Mr. Alejandro Diaz Lopez, Head of Corporate Finance & Investor Relations Officer, will host a conference call to discuss the Company's financial results that same date, at 12:00 PM ET.Alejandro Diaz Lopez+54 11 4317-5000Av. Tomas Alva Edison 2701Dársena E - Puerto de Buenos Aires Ciudad de Buenos AiresRepública Argentina","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/central-puerto-announces-reporting-date-200800688.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/central-puerto-announces-reporting-date-200800688.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CEPU","BK4563","BK4105"],"gpt_icon":0},{"id":"2532832099","title":"REGENXBIO to Host Conference Call on May 12 to Discuss First Quarter 2025 Financial Results and Recent Operational Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2532832099","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532832099?lang=en_us&edition=fundamental","pubTime":"2025-05-01 04:05","pubTimestamp":1746043500,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md., April 30, 2025 /PRNewswire/ -- REGENXBIO Inc.  today announced that it will host a conference call on Monday, May 12, at 4:30 p.m. ET to discuss its financial results for the first quarter ended March 31, 2025, and recent operational highlights.Listeners can register for the webcast via this link. Analysts wishing to participate in the question and answer session should use this link. A replay of the webcast will be available via the company's investor website approximately two hours after the call's conclusion. Those who plan on participating are advised to join 15 minutes prior to the start time.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/regenxbio-host-conference-call-may-200500449.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/regenxbio-host-conference-call-may-200500449.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4588","BK4563","HST","BK4181","RGNX","BK4218","BK4505","BK4585"],"gpt_icon":0},{"id":"2532756064","title":"Why are Bitcoin and altcoins like XRP, Pepe, VeChain going down?                \n\n7 seconds ago","url":"https://stock-news.laohu8.com/highlight/detail?id=2532756064","media":"cryptonews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532756064?lang=en_us&edition=fundamental","pubTime":"2025-05-01 02:35","pubTimestamp":1746038138,"startTime":"0","endTime":"0","summary":"Bitcoin, altcoins, and the stock market are down on Wednesday after a series of weak economic data from the United States.Bitcoin  price dropped below $94,000, much lower than this month’s high of $96,000. Similarly, top altcoins like Ripple , Pepe , and VeChain  dropped by over 5% in the last 24 hours.The total market capitalization of all cryptocurrencies decreased by 3.6% in the same period, falling to $3.03 billion. U.S. stock indices were also in the red, with the Dow Jones Industrial Average was down around 150 points and the tech-heavy Nasdaq 100 fell around 170 points.As a result, Bitcoin and most altcoins, including Pepe, VeChain, and XRP, fell as investors increasingly predicted a looming U.S. recession. In a statement, Mark Zandi, the senior economist at Moody’s, warned that the economy was on the precipice of a recession.Historically, cryptocurrency prices have rallied when the Fed enters a rate-cutting cycle. For example, Bitcoin and most altcoins surged during the pandemi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/why-are-bitcoin-and-altcoins-like-xrp-pepe-vechain-going-down/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["BTC.USD.HKCC","BK4601","US2Y.BOND","US6M.BOND","03439","US3Y.BOND","BTC.AU","BK4588","VET","09042","03008","83042","US30Y.BOND","BK4213","BTC","BK4563","03042","BK1611","09439","09008","BK4594","US10Y.BOND","US12M.BOND","BTC.USD.CC","US7Y.BOND","US5Y.BOND","BK4585"],"gpt_icon":1},{"id":"2532064703","title":"CyberArk Software Ltd. (CYBR): Among Billionaire George Soros’ Mid-Cap Stocks With Huge Upside Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2532064703","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532064703?lang=en_us&edition=fundamental","pubTime":"2025-05-01 02:31","pubTimestamp":1746037919,"startTime":"0","endTime":"0","summary":"We recently published a list of Billionaire George Soros’ 10 Mid-Cap Stocks With Huge Upside Potential. In this article, we are going to take a look at where CyberArk Software Ltd.  stands against other billionaire George Soros’ mid-cap Stocks with huge upside potential.George Sorosis one of the most successful investors in the stock market’s history. He founded the Soros Fund Management, which currently manages over $6.6 billion in assets. His fund often makes contrarian moves that catch the attention of Wall Street and retail investors alike. Alex Soros, one of George Soros’ sons from his second marriage, was handed over the reins in 2023.When investors like George Soros invest in companies, they usually have solid reasons to do so. This is why keeping an eye on their holdings is so important. We decided to take a look at George Soros’ Mid-Cap stock holdings to see what mid-cap stocks he is betting on.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cyberark-software-ltd-cybr-among-183159627.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4081","MMAT","LU1923622291.USD","BK4141","LU2491050154.USD","LU0107464264.USD","LU1559883803.SGD","LU2491049909.HKD","LU2065731478.USD","LU1169590202.USD","LU0566484027.USD","LU1861220033.SGD","LU1169589451.USD","LU2125909759.SGD","LU2286300806.USD","LU2360107168.USD","LU1861215975.USD","BK4560","CYBR","LU2125909916.SGD","BK4097","LU2491050071.SGD","SG9999000418.SGD","LU0053671581.USD","BK4563","LU2290526834.HKD","PAM"],"gpt_icon":0},{"id":"2532066528","title":"Humacyte Insiders Placed Bullish Bets Worth US$949.4k","url":"https://stock-news.laohu8.com/highlight/detail?id=2532066528","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532066528?lang=en_us&edition=fundamental","pubTime":"2025-05-01 00:50","pubTimestamp":1746031840,"startTime":"0","endTime":"0","summary":"Quite a few insiders have dramatically grown their holdings in Humacyte, Inc.  over the past 12 months. An insider's optimism about the company's prospects is a positive sign.Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.Trump has pledged to \"unleash\" American oil and gas and these 15 US stocks have developments that are poised to benefit.The recent insider purchases are heartening. And the longer term insider transactions also give us confidence. However, we note that th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humacyte-insiders-placed-bullish-bets-165040344.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HUMAW","HUMA","BK4139","BK4563"],"gpt_icon":0},{"id":"2531379430","title":"Are Investors Undervaluing Napco Security Technologies, Inc. (NASDAQ:NSSC) By 30%?","url":"https://stock-news.laohu8.com/highlight/detail?id=2531379430","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531379430?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:53","pubTimestamp":1746017591,"startTime":"0","endTime":"0","summary":"Napco Security Technologies' estimated fair value is US$32.51 based on 2 Stage Free Cash Flow to Equity. Current share price of US$22.87 suggests Napco Security Technologies is potentially 30% undervalued. The US$27.20 analyst price target for NSSC is 16% less than our estimate of fair value. How far off is Napco Security Technologies, Inc.  from its intrinsic value?Using the most recent financial data, we'll take a look at whether the stock is fairly priced by estimating the company's future cash flows and discounting them to their present value. We will take advantage of the Discounted Cash Flow  model for this purpose. Models like these may appear beyond the comprehension of a lay person, but they're fairly easy to follow.Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model.  O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/investors-undervaluing-napco-security-technologies-125311893.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NDAQ","BK4157","BK4563","TV","BK4112","PSQ",".IXIC","NSSC","NQmain","BK4100","USAW.SI","BK4585","IE00B64PRP62.GBP","TSYW.SI","ISBC","DCF","QLD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","FCF","SQQQ","LU2210150020.SGD","LU2095319765.USD","USJW.SI","QID","LU2210149790.SGD","IE00BKPKM429.USD","MNQmain","NVIW.SI","BK4588","BK4211","TQQQ"],"gpt_icon":1},{"id":"2531034014","title":"BRIEF-Acurx Pharmaceuticals To Discuss First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2531034014","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531034014?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:41","pubTimestamp":1746016883,"startTime":"0","endTime":"0","summary":"BRIEF-Acurx Pharmaceuticals To Discuss First Quarter 2025 Financial Results April 30 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O:ACURX PHARMACEUTICALS TO DISCUSS FIRST QUARTER 2025 FINANCIAL RESULTS ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUA1QCYYB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACXP","BK4539","BK4563"],"gpt_icon":0},{"id":"2531903124","title":"3 Promising Penny Stocks With Market Caps Up To $400M","url":"https://stock-news.laohu8.com/highlight/detail?id=2531903124","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531903124?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:04","pubTimestamp":1746014690,"startTime":"0","endTime":"0","summary":"The market is up 5.2% over the last week, and in the past year, it has climbed 9.9%, with earnings expected to grow by 14% per annum over the next few years. In light of these positive trends, identifying stocks with strong fundamentals becomes crucial for investors seeking potential growth opportunities. While penny stocks are often associated with smaller or less-established companies, they can offer significant value when backed by robust financial health and clear growth prospects.Underneath we present a selection of stocks filtered out by our screen.Overview: Conduent Incorporated offers digital business solutions and services across the commercial, government, and transportation sectors globally, with a market cap of approximately $344.70 million.Overview: Perfect Corp. is an artificial intelligence software as a service company that offers AI and AR-powered solutions for the beauty, fashion, and skincare industries globally, with a market cap of approximately $195.55 million.Ope","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-promising-penny-stocks-market-120450698.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4173","WDH","BK4209","BK4505","BK4226","PERF","CNDT","TUYA","BK4509","BK4539","BK4563","BK4106","SB","BK4021","BK4179","BABB","TTI","BK4526","BK4023"],"gpt_icon":0},{"id":"2531503566","title":"Acurx Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 13, 2025 Conference Call and Provide Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2531503566","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531503566?lang=en_us&edition=fundamental","pubTime":"2025-04-30 19:30","pubTimestamp":1746012603,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUA1QCYYB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","BK4139","ACXP","BK4539"],"gpt_icon":0},{"id":"2531756035","title":"Acurx Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 13, 2025 Conference Call and Provide Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2531756035","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531756035?lang=en_us&edition=fundamental","pubTime":"2025-04-30 19:30","pubTimestamp":1746012600,"startTime":"0","endTime":"0","summary":"David P. Luci, President and Chief Executive Officer, and Robert G. Shawah, Chief Financial Officer, will host a conference call to discuss the results and provide a business update as follows:. International: Click here for participant international Toll-Free access numbers. Acurx previously announced that it had received positive regulatory guidance from the EMA during its Scientific Advice Procedure which confirmed that the clinical, non-clinical and CMC  information package submitted to EMA supports advancement of the ibezapolstat Phase 3 program and if the Phase 3 program is successful, supports the submission of a Marketing Authorization Application  for regulatory approval in Europe. The information package submitted to EMA by the Company to which agreement has been reached with EMA included details on Acurx's two planned international Phase 3 clinical trials, 1:1 randomized , primary and secondary endpoints, sample size, statistical analysis plan and the overall registration sa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/acurx-pharmaceuticals-discuss-first-quarter-113000266.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acurx-pharmaceuticals-discuss-first-quarter-113000266.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4215","BK4588","BK4135","GAIN","BK4563","BK4585","ACXP","MAA","VRE","BK4139","BK4539","BK4194"],"gpt_icon":0},{"id":"2531039423","title":"NAPCO Security Technologies to Announce Fiscal Third Quarter 2025 Results Monday, May 5, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2531039423","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531039423?lang=en_us&edition=fundamental","pubTime":"2025-04-30 19:30","pubTimestamp":1746012600,"startTime":"0","endTime":"0","summary":"AMITYVILLE, N.Y., April 30, 2025 /PRNewswire/ -- NAPCO Security Technologies, Inc. , one of the leading designers and manufacturers of high-tech electronic security devices, wireless recurring communication services for intrusion, fire alarm, access control and locking systems as well as a leading provider of school safety solutions will release financial results for its Fiscal Third Quarter 2025, which ended March 31, 2025, on Monday May 5, 2025 before the market open followed by a conference call for analysts and investors at 11 A.M. ET.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/napco-security-technologies-announce-fiscal-113000222.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/napco-security-technologies-announce-fiscal-113000222.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NSSC","BK4157","BK4563"],"gpt_icon":0},{"id":"2531392850","title":"Purple Biotech Reports Final Data from Phase 2 Study of CM24 in Pancreatic Cancer Patients at AACR 2025 Annual Meeting: Improved Outcomes and Significant Efficacy in Biomarker-Enriched Subgroups","url":"https://stock-news.laohu8.com/highlight/detail?id=2531392850","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531392850?lang=en_us&edition=fundamental","pubTime":"2025-04-30 19:00","pubTimestamp":1746010800,"startTime":"0","endTime":"0","summary":"Statistically significant efficacy in biomarker subgroup analyses was observed:. 78% reduction in risk of death and 81% reduction in risk of progression or death in defined pretreatment ranges of serum or tumor CEACAM1 subgroup. 61% reduction is risk of death and 72% reduction in risk of progression or death in defined pretreatment ranges of serum CEACAM1 or myeloperoxidase  subgroup. 90% reduction is risk of death and 81% reduction in risk of progression or death in high tumor CEACAM1 and low PD-L1 combined positive score  subgroup. The biomarkers identified in the Phase 2 study are planned to be used for patient selection in the next Phase 2b study. Prolongation of 2.4 months in OS HR=0.81  and prolongation of 1.9 months in PFS HR=0.75  vs. control arm","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/purple-biotech-reports-final-data-110000531.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ORR","PFS","BK4563","IE00BYTNYN87.SGD","BK4554","BK4531","PPBT","TME","01698","IE00BYQNZ168.SGD","BK4613","BK4097","BK4535","LU2039709279.SGD","BK4585","BK4607","SG9999011746.SGD","BK4007","BK4509","BK4571","BK4108","LU0359202008.SGD","LU2286300806.USD","OS","LU1023057109.AUD","BK4552","BK4124","LU0359201612.USD","BK4548","BK4526","IE00B12V2V27.USD","NET","BK4195","BK4560","CPS","BK4116","BK4588","BK4565","BK4211"],"gpt_icon":0},{"id":"2531095797","title":"Uxin Ltd. Reports 116.8% Surge in Transaction Volume for Q4 2024; Achieves Positive Adjusted EBITDA for First Time","url":"https://stock-news.laohu8.com/highlight/detail?id=2531095797","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531095797?lang=en_us&edition=fundamental","pubTime":"2025-04-30 15:40","pubTimestamp":1745998842,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Uxin Ltd. published the original content used to generate this news brief via PR Newswire  on April 30, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nNDL6tMhGc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UXIN","BK4214","BK4505","BK4563","BK4122"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}